Latest Contracts News

Orbital Corporation Ltd reported a positive operating cash flow of $0.7 million for Q1 2025, supported by a solid order book and ongoing development of a new larger capacity engine prototype.

Cue Energy Resources delivered a robust quarter with production rising to 1,700 boe/d and a $7 million dividend payout, while advancing development projects in Australia and Indonesia.

Range International reported a 51% revenue increase in Q1 2025 despite supply chain disruptions that dented cash flow. The company is advancing growth initiatives including pallet rentals in Indonesia and expanding production to the Philippines.

Axiom Properties reported a $200,000 cash reserve decline to $1.658 million for Q1 2025, driven by strong growth in its PaySure business and a pending $7.6 million land sale from its Mount Barker development.

DataWorks Group Limited has secured a two-year extension on its BetStop self-exclusion contract and is advancing its global RegTech pipeline, aiming for positive operating cash flow by December 2025.

Intelligent Monitoring Group Limited (IMG) has reaffirmed its FY25 EBITDA guidance above $38 million, completed the strategic Kobe acquisition, and reported a solid operating cash flow of $6.7 million pre-non-recurring items in Q3 FY25.

Far Northern Resources has secured approval for a major drilling program at Bridge Creek and submitted a renewal for its Empire mining lease, maintaining a robust cash position after modest exploration spending in Q1 2025.

Estrella Resources is set to commence the first-ever minerals drilling program in Timor-Leste, backed by strong manganese assay results and a recent $3.75 million capital raise. The company has secured key environmental approvals and community support, positioning itself at the forefront of exploration in this emerging jurisdiction.

Paradigm Biopharmaceuticals has secured ethics approval and appointed a CRO to launch its global phase 3 trial for injectable Pentosan Polysulfate Sodium in knee osteoarthritis, while initiating a substantial capital raising program.

Hudson Investment Group is actively exploring sale and joint venture opportunities for key properties while managing a negative cash flow quarter, signaling strategic shifts ahead.

Careteq Limited reports strong Q3 FY25 progress with near completion of its 1-System platform integration, revenue growth exceeding forecasts, and new strategic partnerships broadening its healthcare footprint.

Zelira Therapeutics has enhanced its financial flexibility through a $1.15 million R&D tax refund and a $1 million At-the-Market equity facility, while progressing FDA trial preparations for its HOPE® 1 autism treatment.